Remove Clinical Trials Remove DEA Remove Marijuana Remove Policy
article thumbnail

Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators

NORML

Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.

DEA 103
article thumbnail

‘The most meaningful cannabis reform in decades’: Experts weigh in on new DEA rules

The Cannigma

All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We Junk’ cannabis ‘ill-suited for clinical trials’. BRC) told The Cannigma this week.

DEA 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Justice Department Urged To Take “Immediate Action” On Marijuana Grow Applications

NORML

The American Psychological Association (APA) is urging US Attorney General William Barr to review more than two-dozen pending applications for federal marijuana grow licenses. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. .” Also on Wednesday, Rep.

DEA 164
article thumbnail

Legislation To Produce And Research Cannabis Introduced

NORML

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. To date, the US National Institute on Drug Abuse designates the University of Mississippi to be the sole provider of marijuana for FDA-approved research.

article thumbnail

Senators Call For Report On State Of Psychedelic Research

Cannabis Law Report

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. Clinical Trials and Human Subject Protections. Before the drug approval process even begins, sponsors must initiate clinical investigations by first filing an Investigational New Drug Application (IND) with FDA.

article thumbnail

Descheduling Cannabis Will Not Relegate Its Sale Exclusively to Pharmacies; It Will Empower States to Regulate Cannabis as They Seem Fit – Cannabis Business Executive

SpeedWeed

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Authors Tracy Gallegos and Neville M.

article thumbnail

New PTSD study finds cannabis safe, but not as effective as assumed

SpeedWeed

For years, many military veterans have used medical marijuana to manage the symptoms of PTSD. For Veterans With PTSD, Medical Marijuana Can Mean a Good Night’s Sleep. for the production of cannabis used in federally-regulated clinical trials. Wasn’t the DEA going to let others grow research-grade cannabis?